Alerts will be sent to your verified email
Verify Email
VENMAX
|
Venmax Drugs&Pharma
|
Unjha Formulations
|
Decipher Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-44.32 % | 11.14 % | 9.38 % |
|
5yr average Equity Multiplier
|
-0.19 | 1.74 | 2.01 |
|
5yr Average Asset Turnover Ratio
|
0.32 | 3.48 | 1.29 |
|
5yr Avg Net Profit Margin
|
-30.94 % | 1.88 % | 2.8 % |
|
Price to Book
|
2.72 | 3.5 | 0.48 |
|
P/E
|
0.0 | 25.89 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 14.25 Days | -270.54 Days |
|
Inventory Days
|
24.83 Days | 26.1 Days | 1.26 Days |
|
Days Receivable
|
0.0 | 26.23 Days | 89.79 Days |
|
Days Payable
|
189.56 Days | 63.08 Days | 3118.67 Days |
|
5yr Average Interest Coverage Ratio
|
-318.36 | 5.17 | 4.09 |
|
5yr Avg ROCE
|
-45.33 % | 20.73 % | 12.42 % |
|
5yr Avg Operating Profit Margin
|
-50.41 % | 2.93 % | 1.0 % |
|
5 yr average Debt to Equity
|
-0.64 | 0.0 | 0.46 |
|
5yr CAGR Net Profit
|
n/a | -2.02 % | n/a |
|
5yr Average Return on Assets
|
187.49 % | 6.49 % | 3.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
23.13 % | 36.92 % | 16.43 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -17.76 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venmax Drugs&Pharma
|
Unjha Formulations
|
Decipher Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|